High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-κB sites within the HIV-1 LTR correlate with HIV-1-associated dementia

DNA and Cell Biology

Volumn 23, Issue 4, 2004, Pages 261-269

  Burdo, Tricia H ^a   Nonnemacher, Michael ^a   Irish, Bryan P ^b   Choi, Catherine H ^b   Krebs, Fred C ^b   Gartner, Suzanne ^c   Wigdahl, Brian ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CIS ACTING ELEMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS PROTEIN; VPR PROTEIN;

AMINO ACID SEQUENCE; BAY REGION BINDING SITE; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LONG TERMINAL REPEAT; MACROPHAGE; MONOCYTE; NONHUMAN; OLIGONUCLEOTIDE PROBE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS GENE; VIRUS REPLICATION;

AIDS DEMENTIA COMPLEX; BASE SEQUENCE; BRAIN; CCAAT-ENHANCER-BINDING PROTEINS; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE PRODUCTS, VPR; GLUTATHIONE; HIV ENHANCER; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEIN BINDING; SEPHAROSE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 2342512293     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454904773819842     Document Type: Conference Paper

References (27)

1. BRATANICH, A.C., LIU, C., MCARTHUR, L.C., FUDYK, T., GLASS, I.D., MITTOO, S., KLASSEN, G.A., and POWER, C. (1998). Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity. J. Neurovirol. 4, 387-393.
2. CONNOR, R.L., CHEN, B.K., CHOE S., and LANDAU, N.R. (1995). Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935-944.
3. ECKSTEIN, D.A., SHERMAN, M.P., PENN, M.L., CHIN, P.S., DE NORONHA, C.M., GREENE, W.C., and GOLDSMITH, M.A. (2001). HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J. Exp. Med. 194, 1407-1419.
4. EMERMAN, M., and MALIM, M.H. (1998). HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280, 1880-1884.
5. FELZIEN, L.K., WOFFENDIN, C., HOTTIGER, M.O., SUBBRAMANIAN, R.A., COHEN, E.A., and NABEL, G.J. (1998). HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc. Natl. Acad. Sci. USA 95, 5281-5286.
6. HENDERSON, A.J., and CALAME, K.L. (1997). CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc. Natl. Acad. Sci. USA 94, 8714-8719.
7. HENDERSON, A.J., CONNOR, R.L., and CALAME, K.L. (1996). C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5, 91-101.
8. HENDERSON, A.J., ZOU, X., and CALAME, K.L. (1995). C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69, 5337-5344.
9. HOGAN, T.H., KREBS, F.C., and WIGDAHL, B. (2002). Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. J. Neurovirol. 8(Suppl 2), 21-26.
10. HOGAN, T.H., NONNEMACHER, M.R., KREBS, F.C., HENDERSON A., and WIGDAHL, B. (2003a). HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed. Pharmacother. 57, 44-51.
11. HOGAN, T.H., STAUFF, D., KREBS, F.C., GARTNER, S., QUITERIO, S., and WIGDAHL, B. (2003b). Structural and functional evolution of HIV-1 LTR C/EBP sites and their use as molecular markers for CNS disease progression. J. Neurovirol. 9, 1-14.
12. HUANG, M.B., WEEKS, O., ZHAO, L.J., SALTARELLI, M., and BOND, V.C. (2000). Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J. Neurovirol. 6, 202-220.
13. JOHNSTON, J.B., ZHANG, K., SILVA, C., SHALINSKY, D.R., CONANT, K., NI, W., CORBETT, D., YONG, V.W., and POWER, C. (2001). HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann. Neurol. 49, 230-241.
14. KREBS, F.C., GOODENOW, M.M., and WIGDAHL, B. (1997). Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat. J. Neurovirol. 3(Suppl. 1), S28-S32.
15. KREBS, F.C., HOGAN, T.H., QUITERIO, S.J., GARTNER, S., and WIGDAHL, B. (2001). Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. In HIV sequence conpendium 2001. C.L. Kuiken, B. Foley, B. Hahn, B. Korber, F. McCutchan., P.A. Marx, J.W. Mellors, J. Sodroski, and S. Wolinksy, eds. (Theoretical Biology and Biophysics Group, Los Alamo National Laboratory, NM) pp. 1-42.
16. KREBS, F.C., ROSS, H., MCALLISTER, J., and WIGDAHL, B. (2000). HIV-1-associated central nervous system dysfunction. Adv. Pharmacol. 49, 315-385.
17. LAWRENCE, D.M., and MAJOR, E.O. (2002). HIV-1 and the brain: Connections between HIV-1-associated dementia, neuropathology and neuroimmunology. Microbes Infect. 4, 301-308.
18. LEVY, D.N., REFAELI, Y., MACGREGOR, R.R., and WEINER, D.B. (1994). Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 10873-10877.
19. PATEL, C.A., MUKHTAR, M., and POMERANTZ, R.J. (2000). Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J. Virol. 74, 9717-9726.
20. PILLER, S.C., JANS, P., GAGE, P.W., and JANS, D.A. (1998). Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: Implications for AIDS pathology. Proc. Natl. Acad. Sci. USA 95, 4595-4600.
21. ROSS, H.L., GARTNER, S., MCARTHUR, J.C., CORBOY, J.R., MCALLISTER, J.J., MILLHOUSE, S., and WIGDAHL, B. (2001). HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J. Neurovirol. 7, 235-249.
22. ROUX, P., ALFIERI, C., HRIMECH, M., COHEN, E.A., and TANNER, J.E. (2000). Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 74, 4658-4665.
23. SAWAYA, B.E., KHALILI, K., RAPPAPORT, J., SERIO, D., CHEN, W., SRINIVASAN, A., and AMINI, S. (1999). Suppression of HIV-1 transcription and replication by a Vpr mutant. Gene Ther. 6, 947-950.
24. SILVA, C., ZHANG, K., TSUTSUI, S., HOLDEN, I., GILL, M.J., and POWER, C. (2003). Growth hormone prevents human immonodeficiency virus-induced neuronal p53 expression. Ann. Neurol. 54, 605-614.
25. TESMER, V.M., RAJADHYAKSHA, A., BABIN, J., and BINA, M. (1993). NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency viras type 1. Proc. Natl. Acad. Sci. USA 90, 7298-7302.
26. WANG, L., MUKHERJEE, S., JIA, F., NARAYAN, O., and ZHAO, L.J. (1995). Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and transactivation of viral long terminal repeat. J. Biol. Chem. 270, 25564-25569.
27. WITHERS-WARD, E.S., JOWETT, J.B., STEWART, S.A., XIE, Y.M., GARFINKEL, A., SHIBAGAKI, Y., CHOW, S.A., SHAH, N., HANAOKA, E., SAWITZ, D.G., et al. (1997). Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J. Virol. 71, 9732-9742.